Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;19(4):281-283.
doi: 10.2450/2021.0117-21. Epub 2021 Apr 15.

Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)

Paolo Gresele  1 , Marco Marietta  2 , Walter Ageno  3 , Rossella Marcucci  4 , Laura Contino  5 , Marco P Donadini  6 , Laura Russo  7 , Giovanni L Tiscia  8 , Gualtiero Palareti  9 , Armando Tripodi  10 , Pier Mannuccio Mannucci  10 , Valerio De Stefano  11
Affiliations

Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)

Paolo Gresele et al. Blood Transfus. 2021 Jul.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Proposed flow-chart for the management of cerebral sinus or splanchnic vein thrombosis occurring after Vaxzevria vaccine within a timeframe suggesting a causal relationship
aPTT: activated partial thromboplastin time; CSVT: cerebral sinus venous thrombosis; Dex: dexamethasone; FFP: fresh frozen plasma; GFR: glomerular filtration rate; HIPA: heparin-induced platelet aggregation; ICH: intracranial haemorrhage; Ig-HD: high doses of immunoglobulins; INR: international normalised ratio; i.v.: intravenous; LMWH: low-molecular-weight heparin; SVT: splanchnic vein thrombosis; UFH: unfractionated heparin.
See this image and copyright information in PMC

References

    1. Voysey M, Costa Clemens SA, Madhi SA, et al. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. Lancet. 2021;397:881–91. - PMC - PubMed
    1. The BMJ [internet] Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. [Accessed on 09/04/2021.];BMJ. 2021 372:n699. doi: 10.1136/bmj.n699. - DOI - PubMed
    1. The BMJ [internet] Covid-19: EMA defends AstraZeneca vaccine as Germany and Canada halt rollouts. BMJ. 2021. [Accessed on 09/04/2021.]. Available at: https://www.bmj.com/content/373/bmj.n883/rapid-responses. - PubMed
    1. European Medicines Agency (EMA) [internet] COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets. [Accessed on 09/04/2021.]. Available at: https://www.ema.europa.eu/en/news/covid-19-vaccine-astrazeneca-benefits-....
    1. Østergaard SD, Schmidt M, Horváth-Puhó E, et al. Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence? Lancet. 2021;397:1441–3. - PMC - PubMed